PPARG and early-onset autosomal dominant Alzheimer disease: PPAR gamma agonists have been shown to be beneficial in several NDs, such as stroke, Alzheimer’s disease, ALS, Parkinson’s disease, Huntington’s disease, multiple sclerosis.